Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alain Monnereau"'
Autor:
Christian Combe, Alain Monnereau, Julie Preterre, Sébastien Orazio, Claire Rigothier, Maxime Courant
Publikováno v:
Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2021, 36 (3), pp.482-490. ⟨10.1093/ndt/gfz211⟩
Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2021, 36 (3), pp.482-490. ⟨10.1093/ndt/gfz211⟩
Background Renal impairment (RI), a severe complication in multiple myeloma (MM), is considered as a poor prognostic factor. Patient survival has increased with the use of novel drugs and autologous stem-cell transplantation (ASCT). However, specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fbbd696e25f9b62c909eb0772cdf987
http://hdl.handle.net/20.500.12278/79278
http://hdl.handle.net/20.500.12278/79278
Autor:
Muriel Rainfray, Catherine Helmer, Angéline Galvin, Isabelle Baldi, Camille Sabathé, Brice Amadeo, Fleur Delva, Gaëlle Coureau, Simone Mathoulin-Pélissier, Pierre Soubeyran, Pierre Joly, Alain Monnereau
Publikováno v:
Cancer Epidemiology
Cancer Epidemiology, Elsevier, 2018, 55, pp.39-44. ⟨10.1016/j.canep.2018.04.013⟩
Cancer Epidemiology, Elsevier, 2018, 55, pp.39-44. ⟨10.1016/j.canep.2018.04.013⟩
Introduction Several studies have reported disparities in the care management and survival of older cancer patients. The aim of our study was to identify determinants of treatment administration in this population of cancer patients aged over 65 year
Autor:
Alain Monnereau, Sébastien Orazio, Olivier Dejardin, Sandra Le Guyader-Peyrou, Marc Maynadié, Xavier Troussard
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2017, 102 (3), pp.584-592. 〈http://www.haematologica.org/content/102/3/584.long〉. 〈10.3324/haematol.2016.152918〉
Haematologica, Ferrata Storti Foundation, 2017, 102 (3), pp.584-592. ⟨10.3324/haematol.2016.152918⟩
Haematologica, Ferrata Storti Foundation, 2017, 102 (3), pp.584-592. 〈http://www.haematologica.org/content/102/3/584.long〉. 〈10.3324/haematol.2016.152918〉
Haematologica, Ferrata Storti Foundation, 2017, 102 (3), pp.584-592. ⟨10.3324/haematol.2016.152918⟩
IF 7.702; International audience; The survival of patients with diffuse large B-cell lymphoma has increased during the last decade as a result of addition of anti-CD20 to anthracycline-based chemotherapy. Although the trend is encouraging, there are
Autor:
Eric Solary, Julia Bonastre, Stéphanie Foulon, Alain Monnereau, Marc Delord, Agnès Guerci-Bresler, Pascale Tubert-Bitter, Pascale Cony-Makhoul
Publikováno v:
Cancer Medicine
Cancer Medicine, 2019, 8 (6), pp.3296-3304. ⟨10.1002/cam4.2200⟩
Cancer Medicine, Wiley, 2019, 8 (6), pp.3296-3304. ⟨10.1002/cam4.2200⟩
Cancer Medicine, Vol 8, Iss 6, Pp 3296-3304 (2019)
Cancer Medicine, 2019, 8 (6), pp.3296-3304. ⟨10.1002/cam4.2200⟩
Cancer Medicine, Wiley, 2019, 8 (6), pp.3296-3304. ⟨10.1002/cam4.2200⟩
Cancer Medicine, Vol 8, Iss 6, Pp 3296-3304 (2019)
International audience; BACKGROUND: Data on Chronic Myeloid Leukemia (CML) prevalence are scarce. Here we provide an estimation of the prevalence of CML in France for the year 2014 using French national health insurance data.METHODS: We selected pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c382ad0fbf6912000ec47070aa3f1c60
https://hal.science/hal-03212260/file/BPH_Cam_foulon_2019.pdf
https://hal.science/hal-03212260/file/BPH_Cam_foulon_2019.pdf
Autor:
Olivier Hermine, Alain Monnereau, Anne Moreau, Marc Maynadié, Brigitte Trétarre, Remy Gressin, Xavier Troussard, Alix Augustin, Patricia Delafosse, Aurélie Bertaut, Steven Le Gouill, Anne-Sophie Woronoff
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2018, 144 (4), pp.629-635. 〈https://link.springer.com/article/10.1007%2Fs00432-017-2529-9〉. 〈10.1007/s00432-017-2529-9〉
Journal of Cancer Research and Clinical Oncology, 2018, 144 (4), pp.629-635. ⟨10.1007/s00432-017-2529-9⟩
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2018, 144 (4), pp.629-635. ⟨10.1007/s00432-017-2529-9⟩
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2018, 144 (4), pp.629-635. 〈https://link.springer.com/article/10.1007%2Fs00432-017-2529-9〉. 〈10.1007/s00432-017-2529-9〉
Journal of Cancer Research and Clinical Oncology, 2018, 144 (4), pp.629-635. ⟨10.1007/s00432-017-2529-9⟩
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2018, 144 (4), pp.629-635. ⟨10.1007/s00432-017-2529-9⟩
IF 3.503; International audience; PurposeMantle cell lymphoma (MCL) is a rare non-Hodgkin’s lymphoma entity with a poor prognosis. Therapeutic advances have improved the survival of patients enrolled in clinical trials; however, their impact on pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f5d28c69ecc5b36ae277f68e1ff8380
http://hdl.handle.net/20.500.12278/11388
http://hdl.handle.net/20.500.12278/11388
Autor:
X. Troussard, F. Binder-Foucard, Marc Maynadié, S. Le Guyader-Peyrou, Laurent Remontet, Nadine Bossard, Alain Monnereau, Aurélien Belot
Publikováno v:
Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique
Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2016, 64 (2), pp.103-112. ⟨10.1016/j.respe.2015.12.017⟩
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2016, 64 (2), pp.103-112. ⟨10.1016/j.respe.2015.12.017⟩
Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2016, 64 (2), pp.103-112. 〈http://www.em-consulte.com/article/1045076/alertePM〉. 〈10.1016/j.respe.2015.12.017〉
Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2016, 64 (2), pp.103-112. ⟨10.1016/j.respe.2015.12.017⟩
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2016, 64 (2), pp.103-112. ⟨10.1016/j.respe.2015.12.017⟩
Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2016, 64 (2), pp.103-112. 〈http://www.em-consulte.com/article/1045076/alertePM〉. 〈10.1016/j.respe.2015.12.017〉
International audience; BACKGROUND:The classification of hematological malignancies (HMs) has changed in recent decades. For the first time, the French network of cancer registries (Francim) provides estimates for incidence and trends of HM in France
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe832a37c39a5fc18132b0f5b4b212ad
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01511580
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01511580
Autor:
Olivier Ganry, Laetitia Daubisse-Marliac, Mylène Dandoit, Xavier Troussard, Anne-Valérie Guizard, Brigitte Trétarre, Alain Monnereau, Marc Maynadié, Véronique Bouvier, Michel Velten, Jérémie Jégu, Morgane Mounier, Marc Colonna, Anne-Sophie Woronoff, Simona Bara, Cédric Rossi, Olivier Casasnovas
Publikováno v:
Leukemialymphoma. 56(10)
Non-Hodgkin lymphoma (NHL) represents a heterogeneous group of diseases that are known to carry a considerable risk of second primary cancer (SPC). However, little attention has been paid to SPC risk assessment according to NHL subtypes. Data from 10
Autor:
Anne-Sophie Woronoff, Albert Collignon, Xavier Troussard, Dominique Bordessoule, Vinciane Dufour, Marc Maynadié, Pierre-Marie Preux, Amélie Penot, Sandra Le Guyader, Aurélie Herry, Alain Monnereau, Elisabeth Pons
Publikováno v:
Leukemialymphoma. 56(6)
The treatment of chronic myeloid leukemia (CML) has seen several major advances over the past 30 years, notably with the introduction of interferon followed by Bcr-Abl tyrosine kinase inhibitors. We analyzed trends in the incidence of CML and patient
Autor:
Alain Monnereau, Xavier Troussard, Marc Maynadié, Quentin Cabrera, Sandra Le Guyader-Peyrou, Aurélie Herry, Steven Le Gouill, Christophe Leux
Publikováno v:
Annals of hematology. 93(8)
Only limited population-based data are available on mantle cell lymphoma (MCL), a relatively rare and aggressive mature B cell non-Hodgkin lymphoma (NHL) entity. We conducted an epidemiological study based on the three French registries devoted to ha